Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood-based biomarkers of frailty in solid tumors: a systematic review.

Frontiers in public health - 1 Jan 2023

Sass Dilorom, Parmelee Streck Brennan, Guedes Vivian A, Cooper Diane, Guida Jennifer L, Armstrong Terri S

Abstract excerpt

This review examines the current literature to identify biomarkers of frailty across patients with solid tumors. We conducted the systematic review using preferred reporting items for systematic reviews and meta-analysis guidelines (PRISMA). PubMed, Web of Science, and Embase databases were searched from their inception to December 08, 2021, for reports of biomarkers and frailty. Two reviewers independently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers
Share to Frailty

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Geriatric Assessment

Share to Neoplasms

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37213604
DOI: 10.3389/fpubh.2023.1171243
PMCID: PMC10193038

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood-based biomarkers of frailty in solid tumors: a systematic review.PMID 37213604Read ↗

A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes.Semantic proximity Read ↗

Frailty biomarkers in humans and rodents: Current approaches and future advancesSemantic proximity Read ↗

Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for InterventionsSemantic proximity Read ↗

Inflammatory Markers and Clinical Factors as Key Independent Risk Factors for Frailty: A Retrospective StudySemantic proximity Read ↗

The "fat heat-up" phenotype: adipose tissue hypermetabolism on 18 F-FDG PET/CT predicts frailty in older patients with solid tumours.Semantic proximity Read ↗

Novel proteomic subtypes of frailty with distinct molecular patterns and prognosis.Semantic proximity Read ↗

Organ-specific cancer biomarker identification: a ten-year single-center study in southern ChinaSemantic proximity Read ↗

Association between frailty and chemotherapy toxicity in patients with gastrointestinal tumors: A prospective observational studySemantic proximity Read ↗

Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple MyelomaSemantic proximity Read ↗

miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty SyndromeSemantic proximity Read ↗

Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.Semantic proximity Read ↗

Exploring Frailty in the Intersection of Cardiovascular Disease and Cancer in Older PeopleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.